Health Care & Life Sciences » Pharmaceuticals | Coland Holdings Ltd.

Coland Holdings Ltd. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
930
631
562
353
540
863
Total Accounts Receivable
516
794
977
1,142
825
705
Inventories
194
283
253
178
253
249
Other Current Assets
243
98
112
169
154
-
Total Current Assets
1,883
1,806
1,904
1,842
1,771
1,816
Net Property, Plant & Equipment
13
200
242
230
230
210
Total Investments and Advances
1,149
1,227
1,099
988
569
1,032
Intangible Assets
615
1,169
1,088
953
870
800
Other Assets
1
1
8
7
185
566
Total Assets
3,686
4,413
4,352
4,025
3,633
4,436
ST Debt & Current Portion LT Debt
-
261
579
907
725
Accounts Payable
3
58
15
20
37
Income Tax Payable
23
21
48
46
20
Other Current Liabilities
231
265
185
381
243
Total Current Liabilities
257
606
827
1,354
1,025
Deferred Taxes
50
116
98
82
65
Other Liabilities
85
169
75
-
-
Total Liabilities
418
900
1,010
1,441
1,098
Common Equity (Total)
3,050
3,100
2,871
2,261
2,194
Total Shareholders' Equity
3,050
3,100
2,871
2,261
2,194
Total Equity
3,268
3,514
3,341
2,584
2,535
Liabilities & Shareholders' Equity
3,686
4,413
4,352
4,025
3,633
Accumulated Minority Interest
218
414
471
323
342

About Coland Holdings

View Profile
Address
2nd Floor
Shanghai Shanghai
China
Employees -
Website http://www.colandpharma.com
Updated 07/08/2019
Coland Holdings Ltd. engages in the development and sale of pharmaceutical products and medical devices. Its products include generic medicines, traditional Chinese patent medicines, biochemical drugs, and medical equipment. The company also sell orthopedic, dental and ophthalmology medical devices.